11:02 AM EDT, 06/16/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,497.18 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and DBV Technologies ( DBVT ) , which rose 5.2% and 4.7% respectively. They were followed by telecommunications operator Telefonica ( TEF ) and Spanish lender Banco Santander (SAN), which were up 4.2% and 3.7% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and biotech firm Evaxion ( EVAX ) , which fell 2.8% and 2.3% respectively. They were followed by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications ( SQNS ) , which were down 2.1% and 1.8% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and Adaptimmune Therapeutics ( ADAP ) , which advanced 19% and 5.1% respectively. They were followed by cruise line operator Carnival (CUK) and telecommunications operator Vodafone Group ( VOD ) , which increased 5% and 3.5% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which dropped 2.8% and 2.5% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which were off 2% and 1.9% respectively.